$SCMP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sucampo Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sucampo Pharmaceuticals, Inc.. Get notifications about new insider transactions in Sucampo Pharmaceuticals, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | OCONNELL MAUREEN | Director | Option Exercise | D | 10.30 | 10,000 | 103,000 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | OCONNELL MAUREEN | Director | Option Exercise | D | 16.23 | 20,000 | 324,600 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | OCONNELL MAUREEN | Director | Option Exercise | D | 6.80 | 20,000 | 136,000 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | OCONNELL MAUREEN | Director | Option Exercise | D | 8.62 | 20,000 | 172,400 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | OCONNELL MAUREEN | Director | Option Exercise | D | 5.19 | 30,000 | 155,700 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | OCONNELL MAUREEN | Director | Sell | D | 18.00 | 5,130 | 92,340 | 0 | 5.1 K to 0 (-100.00 %) |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Spiegel Robert J. | Director | Option Exercise | D | 10.30 | 10,000 | 103,000 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Spiegel Robert J. | Director | Option Exercise | D | 16.23 | 20,000 | 324,600 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Spiegel Robert J. | Director | Option Exercise | D | 14.04 | 30,000 | 421,200 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Spiegel Robert J. | Director | Sell | D | 18.00 | 5,130 | 92,340 | 0 | 5.1 K to 0 (-100.00 %) |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Smith Karen L. | Director | Option Exercise | D | 10.95 | 30,000 | 328,500 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Option Exercise | D | 10.30 | 10,000 | 103,000 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Option Exercise | D | 16.23 | 20,000 | 324,600 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Option Exercise | D | 13.92 | 30,000 | 417,600 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Sell | D | 18.00 | 5,130 | 92,340 | 0 | 5.1 K to 0 (-100.00 %) |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Option Exercise | D | 11.85 | 133,000 | 1,576,050 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Option Exercise | D | 13.80 | 87,203 | 1,203,401 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Option Exercise | D | 14.82 | 38,500 | 570,570 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Option Exercise | D | 8.33 | 250,000 | 2,082,500 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Sell | D | 18.00 | 44,856 | 807,408 | 0 | 44.9 K to 0 (-100.00 %) |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | PFREUNDSCHUH PETER P. | CFO | Option Exercise | D | 10.90 | 150,000 | 1,635,000 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | PFREUNDSCHUH PETER P. | CFO | Sell | D | 18.00 | 263 | 4,734 | 0 | 263 to 0 (-100.00 %) |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Meyenburg Jason Patrick | Chief Commercial Of ... | Option Exercise | D | 10.65 | 150,000 | 1,597,500 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Meyenburg Jason Patrick | Chief Commercial Of ... | Sell | D | 18.00 | 30,228 | 544,104 | 0 | 30.2 K to 0 (-100.00 %) |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Driggs Alex | General Counsel & C ... | Option Exercise | D | 11.85 | 11,068 | 131,156 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Driggs Alex | General Counsel & C ... | Option Exercise | D | 13.80 | 24,150 | 333,270 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Driggs Alex | General Counsel & C ... | Option Exercise | D | 16.04 | 25,600 | 410,624 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Driggs Alex | General Counsel & C ... | Sell | D | 18.00 | 6,084 | 109,512 | 0 | 6.1 K to 0 (-100.00 %) |
| Jan 12 2018 | SCMP | Sucampo Pharmaceut ... | PFREUNDSCHUH PETER P. | CFO | Grant | A | 9.10 | 263 | 2,393 | 263 | 0 to 263 |
| Jan 12 2018 | SCMP | Sucampo Pharmaceut ... | PFREUNDSCHUH PETER P. | CFO | Grant | A | 9.10 | 131 | 1,192 | 131 | 0 to 131 |
| Jan 12 2018 | SCMP | Sucampo Pharmaceut ... | Bryan Jones W. | Sr. Vice Pres., BD ... | Grant | A | 10.24 | 439 | 4,495 | 5,139 | 4.7 K to 5.1 K (+9.34 %) |
| Jan 04 2018 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | Chief Executive Off ... | Grant | A | 9.10 | 171 | 1,556 | 4,792 | 4.6 K to 4.8 K (+3.70 %) |
| Jan 04 2018 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Grant | A | 9.10 | 329 | 2,994 | 44,856 | 44.5 K to 44.9 K (+0.74 %) |
| Jan 04 2018 | SCMP | Sucampo Pharmaceut ... | Donley Matthew Maxwell | EVP, Global HR, IT ... | Grant | A | 9.10 | 330 | 3,003 | 36,975 | 36.6 K to 37 K (+0.90 %) |
| Jan 04 2018 | SCMP | Sucampo Pharmaceut ... | Driggs Alex | General Counsel & C ... | Grant | A | 9.10 | 660 | 6,006 | 6,084 | 5.4 K to 6.1 K (+12.17 %) |
| Jan 02 2018 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Payment of Exercise | F | 17.98 | 27,496 | 494,378 | 44,527 | 72 K to 44.5 K (-38.18 %) |
| Jan 02 2018 | SCMP | Sucampo Pharmaceut ... | Donley Matthew Maxwell | EVP, Global HR, IT ... | Payment of Exercise | F | 17.98 | 19,353 | 347,967 | 36,645 | 56 K to 36.6 K (-34.56 %) |
| Jan 02 2018 | SCMP | Sucampo Pharmaceut ... | Driggs Alex | General Counsel & C ... | Payment of Exercise | F | 17.98 | 2,025 | 36,410 | 5,424 | 7.4 K to 5.4 K (-27.18 %) |
| Dec 11 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Option Exercise | M | 8.33 | 50,000 | 416,500 | 242,567 | |
| Dec 11 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Sell | S | 16.50 | 50,000 | 825,000 | 2,023 | 52 K to 2 K (-96.11 %) |
| Dec 11 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Buy | M | 8.33 | 50,000 | 416,500 | 52,023 | 2 K to 52 K (+2,471.58 %) |
| Oct 05 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Grant | A | 9.10 | 330 | 3,003 | 2,023 | 1.7 K to 2 K (+19.49 %) |
| Oct 05 2017 | SCMP | Sucampo Pharmaceut ... | Donley Matthew Maxwell | EVP, Global HR, IT ... | Grant | A | 9.10 | 330 | 3,003 | 2,998 | 2.7 K to 3 K (+12.37 %) |
| Oct 05 2017 | SCMP | Sucampo Pharmaceut ... | Driggs Alex | General Counsel & C ... | Grant | A | 9.10 | 659 | 5,997 | 1,331 | 672 to 1.3 K (+98.07 %) |
| Oct 05 2017 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | CEO | Grant | A | 9.10 | 659 | 5,997 | 4,621 | 4 K to 4.6 K (+16.63 %) |
| Sep 13 2017 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | 10% Owner | Sell | S | 12.00 | 1,000,000 | 12,000,000 | 8,006,585 | 9 M to 8 M (-11.10 %) |
| Sep 13 2017 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 12.00 | 1,000,000 | 12,000,000 | 7,137,344 | 8.1 M to 7.1 M (-12.29 %) |
| Sep 08 2017 | SCMP | Sucampo Pharmaceut ... | Meyenburg Jason Patrick | Chief Commercial Of ... | Buy | P | 12.13 | 4,000 | 48,500 | 30,228 | 26.2 K to 30.2 K (+15.25 %) |
| Aug 07 2017 | SCMP | Sucampo Pharmaceut ... | Bryan Jones W. | Sr. Vice Pres., BD ... | Buy | P | 10.60 | 4,700 | 49,820 | 4,700 | 0 to 4.7 K |
| Jul 07 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Grant | A | 8.93 | 336 | 3,000 | 1,693 | 1.4 K to 1.7 K (+24.76 %) |
| Jul 07 2017 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | CEO | Grant | A | 8.93 | 673 | 6,010 | 3,962 | 3.3 K to 4 K (+20.46 %) |
| Jul 07 2017 | SCMP | Sucampo Pharmaceut ... | Driggs Alex | Acting General Coun ... | Grant | A | 8.93 | 672 | 6,001 | 672 | 0 to 672 |
| Jul 07 2017 | SCMP | Sucampo Pharmaceut ... | Donley Matthew Maxwell | EVP, Global HR, IT ... | Grant | A | 8.93 | 336 | 3,000 | 2,668 | 2.3 K to 2.7 K (+14.41 %) |
| Jul 07 2017 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Gen. Council & ... | Grant | A | 8.93 | 673 | 6,010 | 4,763 | 4.1 K to 4.8 K (+16.45 %) |
| Jun 05 2017 | SCMP | Sucampo Pharmaceut ... | Edick Paul R | Director | Option Exercise | A | 10.30 | 10,000 | 103,000 | 10,000 | |
| Jun 05 2017 | SCMP | Sucampo Pharmaceut ... | Edick Paul R | Director | Grant | A | 0.00 | 5,130 | 0 | 14,930 | 9.8 K to 14.9 K (+52.35 %) |
| Jun 05 2017 | SCMP | Sucampo Pharmaceut ... | Walbert Timothy P | Director | Option Exercise | A | 10.30 | 10,000 | 103,000 | 40,000 | |
| Jun 05 2017 | SCMP | Sucampo Pharmaceut ... | Walbert Timothy P | Director | Grant | A | 0.00 | 5,130 | 0 | 14,930 | 9.8 K to 14.9 K (+52.35 %) |
| Jun 05 2017 | SCMP | Sucampo Pharmaceut ... | Spiegel Robert J. | Director | Option Exercise | A | 10.30 | 10,000 | 103,000 | 60,000 | |
| Jun 05 2017 | SCMP | Sucampo Pharmaceut ... | Spiegel Robert J. | Director | Grant | A | 0.00 | 5,130 | 0 | 14,930 | 9.8 K to 14.9 K (+52.35 %) |
| Jun 05 2017 | SCMP | Sucampo Pharmaceut ... | OCONNELL MAUREEN | Director | Option Exercise | A | 10.30 | 10,000 | 103,000 | 100,000 | |
| Jun 05 2017 | SCMP | Sucampo Pharmaceut ... | OCONNELL MAUREEN | Director | Grant | A | 0.00 | 5,130 | 0 | 14,930 | 9.8 K to 14.9 K (+52.35 %) |
| Jun 05 2017 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Option Exercise | A | 10.30 | 10,000 | 103,000 | 60,000 | |
| Jun 05 2017 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 5,130 | 0 | 14,930 | 9.8 K to 14.9 K (+52.35 %) |
| May 10 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Grant | A | 9.35 | 321 | 3,001 | 1,357 | 1 K to 1.4 K (+30.98 %) |
| May 10 2017 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | CEO | Grant | A | 9.35 | 641 | 5,993 | 3,289 | 2.6 K to 3.3 K (+24.21 %) |
| May 10 2017 | SCMP | Sucampo Pharmaceut ... | Donley Matthew Maxwell | EVP, Global HR, IT ... | Grant | A | 9.35 | 321 | 3,001 | 2,332 | 2 K to 2.3 K (+15.96 %) |
| May 10 2017 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Gen. Council & ... | Grant | A | 9.35 | 641 | 5,993 | 4,224 | 3.6 K to 4.2 K (+17.89 %) |
| Mar 22 2017 | SCMP | Sucampo Pharmaceut ... | PFREUNDSCHUH PETER P. | CFO | Option Exercise | A | 10.90 | 150,000 | 1,635,000 | 150,000 | |
| Mar 08 2017 | SCMP | Sucampo Pharmaceut ... | Lichtlen Peter | Chief Medical Offic ... | Option Exercise | A | 11.85 | 45,000 | 533,250 | 314,400 | |
| Mar 08 2017 | SCMP | Sucampo Pharmaceut ... | Lichtlen Peter | Chief Medical Offic ... | Grant | A | 0.00 | 24,000 | 0 | 24,000 | 0 to 24 K |
| Mar 08 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Scientific Of ... | Option Exercise | A | 11.85 | 133,000 | 1,576,050 | 626,270 | |
| Mar 08 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Scientific Of ... | Grant | A | 0.00 | 70,000 | 0 | 70,000 | 0 to 70 K |
| Mar 08 2017 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | Chief Executive Off ... | Option Exercise | A | 11.85 | 237,000 | 2,808,450 | 1,667,000 | |
| Mar 08 2017 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | Chief Executive Off ... | Grant | A | 0.00 | 125,000 | 0 | 125,000 | 0 to 125 K |
| Mar 08 2017 | SCMP | Sucampo Pharmaceut ... | Donley Matthew Maxwell | EVP, Human Resource ... | Option Exercise | A | 11.85 | 101,000 | 1,196,850 | 379,000 | |
| Mar 08 2017 | SCMP | Sucampo Pharmaceut ... | Donley Matthew Maxwell | EVP, Human Resource ... | Grant | A | 0.00 | 53,000 | 0 | 53,000 | 0 to 53 K |
| Mar 08 2017 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Bus.Dev.&Lic., ... | Option Exercise | A | 11.85 | 63,000 | 746,550 | 325,500 | |
| Mar 08 2017 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Bus.Dev.&Lic., ... | Grant | A | 0.00 | 33,000 | 0 | 33,000 | 0 to 33 K |
| Jan 06 2017 | SCMP | Sucampo Pharmaceut ... | Smith Andrew P | Chief Financial Off ... | Grant | A | 10.46 | 143 | 1,496 | 491 | 348 to 491 (+41.09 %) |
| Jan 06 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Scientific Of ... | Grant | A | 10.46 | 287 | 3,002 | 1,036 | 749 to 1 K (+38.32 %) |
| Jan 06 2017 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | Chief Executive Off ... | Grant | A | 10.46 | 135 | 1,412 | 2,648 | 2.5 K to 2.6 K (+5.37 %) |
| Jan 06 2017 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Bus. Dev.&Lic, ... | Grant | A | 10.46 | 134 | 1,402 | 3,583 | 3.4 K to 3.6 K (+3.89 %) |
| Dec 29 2016 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | 10% Owner | Gift | G | 0.00 | 130,760 | 0 | 0 | 130.8 K to 0 (-100.00 %) |
| Dec 29 2016 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Gift | G | 0.00 | 1,000,000 | 0 | 0 | 1000 K to 0 (-100.00 %) |
| Dec 21 2016 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | Sell | J | 0.00 | 18,274,689 | 0 | 0 | 18.3 M to 0 (-100.00 %) | |
| Nov 30 2016 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | CEO | Option Exercise | M | 6.75 | 82,459 | 556,598 | 1,430,000 | |
| Nov 30 2016 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | CEO | Option Exercise | M | 6.75 | 117,541 | 793,402 | 1,512,459 | |
| Nov 30 2016 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | CEO | Sell | S | 16.75 | 82,459 | 1,381,188 | 2,513 | 85 K to 2.5 K (-97.04 %) |
| Nov 30 2016 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | CEO | Buy | M | 6.75 | 82,459 | 556,598 | 84,972 | 2.5 K to 85 K (+3,281.30 %) |
| Nov 30 2016 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | CEO | Sell | S | 16.91 | 117,541 | 1,987,618 | 2,513 | 120.1 K to 2.5 K (-97.91 %) |
| Nov 30 2016 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | CEO | Buy | M | 6.75 | 117,541 | 793,402 | 120,054 | 2.5 K to 120.1 K (+4,677.32 %) |
| Nov 30 2016 | SCMP | Sucampo Pharmaceut ... | Getman Daniel P | Director | Option Exercise | M | 6.80 | 3,799 | 25,833 | 60,000 | |
| Nov 30 2016 | SCMP | Sucampo Pharmaceut ... | Getman Daniel P | Director | Option Exercise | M | 6.80 | 16,201 | 110,167 | 63,799 | |
| Nov 30 2016 | SCMP | Sucampo Pharmaceut ... | Getman Daniel P | Director | Sell | S | 16.75 | 3,799 | 63,633 | 0 | 3.8 K to 0 (-100.00 %) |
| Nov 30 2016 | SCMP | Sucampo Pharmaceut ... | Getman Daniel P | Director | Buy | M | 6.80 | 3,799 | 25,833 | 3,799 | 0 to 3.8 K |
| Nov 30 2016 | SCMP | Sucampo Pharmaceut ... | Getman Daniel P | Director | Sell | S | 16.89 | 16,201 | 273,635 | 0 | 16.2 K to 0 (-100.00 %) |
| Nov 30 2016 | SCMP | Sucampo Pharmaceut ... | Getman Daniel P | Director | Buy | M | 6.80 | 16,201 | 110,167 | 16,201 | 0 to 16.2 K |
| Nov 28 2016 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Bus. Dev.&Lic, ... | Option Exercise | M | 8.33 | 24,975 | 208,042 | 262,500 | |
| Nov 28 2016 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Bus. Dev.&Lic, ... | Option Exercise | M | 8.33 | 99,025 | 824,878 | 287,475 | |
| Nov 28 2016 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Bus. Dev.&Lic, ... | Option Exercise | M | 8.33 | 26,000 | 216,580 | 386,500 | |
| Nov 28 2016 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Bus. Dev.&Lic, ... | Sell | S | 16.73 | 24,975 | 417,832 | 3,449 | 28.4 K to 3.4 K (-87.87 %) |
| Nov 28 2016 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Bus. Dev.&Lic, ... | Buy | M | 8.33 | 24,975 | 208,042 | 28,424 | 3.4 K to 28.4 K (+724.12 %) |
| Nov 28 2016 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Bus. Dev.&Lic, ... | Sell | S | 15.88 | 99,025 | 1,572,517 | 3,449 | 102.5 K to 3.4 K (-96.63 %) |
| Nov 28 2016 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Bus. Dev.&Lic, ... | Buy | M | 8.33 | 99,025 | 824,878 | 102,474 | 3.4 K to 102.5 K (+2,871.12 %) |
| Nov 28 2016 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Bus. Dev.&Lic, ... | Sell | S | 15.77 | 26,000 | 410,020 | 3,449 | 29.4 K to 3.4 K (-88.29 %) |
| Nov 28 2016 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Bus. Dev.&Lic, ... | Buy | M | 8.33 | 26,000 | 216,580 | 29,449 | 3.4 K to 29.4 K (+753.84 %) |
| Nov 16 2016 | SCMP | Sucampo Pharmaceut ... | Smith Andrew P | Chief Financial Off ... | Sell | S | 15.58 | 1,766 | 27,514 | 348 | 2.1 K to 348 (-83.54 %) |
| Oct 21 2016 | SCMP | Sucampo Pharmaceut ... | Smith Andrew P | Chief Financial Off ... | Grant | A | 9.38 | 160 | 1,501 | 2,114 | 2 K to 2.1 K (+8.19 %) |
| Oct 21 2016 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Scientific Of ... | Grant | A | 9.38 | 320 | 3,002 | 749 | 429 to 749 (+74.59 %) |
| Oct 21 2016 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | Chief Executive Off ... | Grant | A | 9.38 | 640 | 6,003 | 2,513 | 1.9 K to 2.5 K (+34.17 %) |
| Oct 21 2016 | SCMP | Sucampo Pharmaceut ... | Donley Matthew Maxwell | Exec.VicePres,Human ... | Grant | A | 9.38 | 320 | 3,002 | 1,725 | 1.4 K to 1.7 K (+22.78 %) |
| Oct 21 2016 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Bus. Dev.&Lic, ... | Grant | A | 9.38 | 639 | 5,994 | 3,449 | 2.8 K to 3.4 K (+22.74 %) |
| Aug 03 2016 | SCMP | Sucampo Pharmaceut ... | Edick Paul R | Director | Grant | A | 0.00 | 14,700 | 0 | 14,700 | 0 to 14.7 K |
| Jul 18 2016 | SCMP | Sucampo Pharmaceut ... | Smith Andrew P | Chief Financial Off ... | Grant | A | 9.32 | 188 | 1,752 | 1,954 | 1.8 K to 2 K (+10.65 %) |
| Jul 18 2016 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Scientific Of ... | Grant | A | 9.32 | 300 | 2,796 | 429 | 129 to 429 (+232.56 %) |
| Jul 18 2016 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | Chief Executive Off ... | Grant | A | 9.32 | 751 | 6,999 | 1,873 | 1.1 K to 1.9 K (+66.93 %) |
| Jul 18 2016 | SCMP | Sucampo Pharmaceut ... | Donley Matthew Maxwell | Exec. V.P., Human R ... | Grant | A | 9.32 | 376 | 3,504 | 1,405 | 1 K to 1.4 K (+36.54 %) |
| Jul 18 2016 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Bus. Dev.&Lic, ... | Grant | A | 9.32 | 752 | 7,009 | 2,810 | 2.1 K to 2.8 K (+36.54 %) |
| Jun 16 2016 | SCMP | Sucampo Pharmaceut ... | Smith Andrew P | Chief Financial Off ... | Grant | A | 9.29 | 161 | 1,496 | 1,766 | 1.6 K to 1.8 K (+10.03 %) |
| Jun 16 2016 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Scientific Of ... | Grant | A | 9.29 | 129 | 1,198 | 129 | 0 to 129 |
| Jun 16 2016 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | Chief Executive Off ... | Grant | A | 9.29 | 646 | 6,001 | 1,122 | 476 to 1.1 K (+135.71 %) |
| Jun 16 2016 | SCMP | Sucampo Pharmaceut ... | Donley Matthew Maxwell | Exec. V.P., Human R ... | Grant | A | 9.29 | 323 | 3,001 | 1,029 | 706 to 1 K (+45.75 %) |
| Jun 16 2016 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Bus.Dev.&Lic, ... | Grant | A | 9.29 | 645 | 5,992 | 2,058 | 1.4 K to 2.1 K (+45.65 %) |
| Jun 06 2016 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 9,800 | 0 | 9,800 | 0 to 9.8 K |
| Jun 06 2016 | SCMP | Sucampo Pharmaceut ... | Walbert Timothy P | Director | Grant | A | 0.00 | 9,800 | 0 | 9,800 | 0 to 9.8 K |
| Jun 06 2016 | SCMP | Sucampo Pharmaceut ... | OCONNELL MAUREEN | Director | Grant | A | 0.00 | 9,800 | 0 | 9,800 | 0 to 9.8 K |
| Jun 06 2016 | SCMP | Sucampo Pharmaceut ... | Spiegel Robert J. | Director | Grant | A | 0.00 | 9,800 | 0 | 9,800 | 0 to 9.8 K |
| Jun 06 2016 | SCMP | Sucampo Pharmaceut ... | Getman Daniel P | Director | Grant | A | 0.00 | 9,800 | 0 | 9,800 | 0 to 9.8 K |
| Mar 04 2016 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | Chief Executive Off ... | Option Exercise | A | 13.80 | 420,000 | 5,796,000 | 1,630,000 | |
| Mar 04 2016 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | Chief Executive Off ... | Grant | A | 14.70 | 476 | 6,997 | 476 | 0 to 476 |
| Mar 04 2016 | SCMP | Sucampo Pharmaceut ... | Smith Andrew P | Chief Financial Off ... | Option Exercise | A | 13.80 | 57,000 | 786,600 | 215,600 | |
| Mar 04 2016 | SCMP | Sucampo Pharmaceut ... | Lichtlen Peter | Chief Medical Offic ... | Option Exercise | A | 13.80 | 44,000 | 607,200 | 269,400 | |
| Mar 04 2016 | SCMP | Sucampo Pharmaceut ... | Donley Matthew Maxwell | Exec. V.P., Human R ... | Option Exercise | A | 13.80 | 75,000 | 1,035,000 | 278,000 | |
| Mar 04 2016 | SCMP | Sucampo Pharmaceut ... | Donley Matthew Maxwell | Exec. V.P., Human R ... | Grant | A | 14.70 | 238 | 3,499 | 706 | 468 to 706 (+50.85 %) |
| Mar 04 2016 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Scientific Of ... | Option Exercise | A | 13.80 | 116,270 | 1,604,526 | 493,270 | |
| Mar 04 2016 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Business Dev. ... | Option Exercise | A | 13.80 | 62,500 | 862,500 | 412,500 | |
| Mar 04 2016 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Business Dev. ... | Grant | A | 14.70 | 477 | 7,012 | 1,413 | 936 to 1.4 K (+50.96 %) |
| Nov 20 2015 | SCMP | Sucampo Pharmaceut ... | Donley Matthew Maxwell | Exec. V.P., Human R ... | Grant | A | 14.52 | 207 | 3,006 | 468 | 261 to 468 (+79.31 %) |
| Nov 20 2015 | SCMP | Sucampo Pharmaceut ... | Donley Matthew Maxwell | Exec. V.P., Human R ... | Grant | A | 13.37 | 261 | 3,490 | 261 | 0 to 261 |
| Nov 20 2015 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Business Dev. ... | Option Exercise | A | 14.82 | 50,000 | 741,000 | 350,000 | |
| Nov 20 2015 | SCMP | Sucampo Pharmaceut ... | Miele Stanley G | Chief Commercial Of ... | Grant | A | 14.52 | 41 | 595 | 93 | 52 to 93 (+78.85 %) |
| Nov 20 2015 | SCMP | Sucampo Pharmaceut ... | Miele Stanley G | Chief Commercial Of ... | Grant | A | 13.37 | 52 | 695 | 52 | 0 to 52 |
| Nov 20 2015 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Business Dev. ... | Grant | A | 14.52 | 413 | 5,997 | 936 | 523 to 936 (+78.97 %) |
| Nov 20 2015 | SCMP | Sucampo Pharmaceut ... | Alder Matthias | EVP, Business Dev. ... | Grant | A | 13.37 | 523 | 6,993 | 523 | 0 to 523 |
| Nov 18 2015 | SCMP | Sucampo Pharmaceut ... | Smith Andrew P | Chief Financial Off ... | Buy | P | 17.03 | 1,605 | 27,333 | 1,605 | 0 to 1.6 K |
| Oct 14 2015 | SCMP | Sucampo Pharmaceut ... | Walbert Timothy P | Director | Option Exercise | A | 18.40 | 30,000 | 552,000 | 30,000 | |
| Aug 31 2015 | SCMP | Sucampo Pharmaceut ... | Getman Daniel P | Director | Option Exercise | M | 3.20 | 30,000 | 96,000 | 80,000 | |
| Aug 31 2015 | SCMP | Sucampo Pharmaceut ... | Getman Daniel P | Director | Sell | S | 28.14 | 30,000 | 844,200 | 0 | 30 K to 0 (-100.00 %) |
| Aug 31 2015 | SCMP | Sucampo Pharmaceut ... | Getman Daniel P | Director | Buy | M | 3.20 | 30,000 | 96,000 | 30,000 | 0 to 30 K |